TGFB1 and breast carcinoma: M2-like TAMs isolated from spontaneous mouse mammary carcinomas as well as differentiated ex vivo from the peritoneum or bone marrow of healthy mice have been shown to potently inhibit NK cell cytotoxicity coupled to the acquisition of an exhausted CD27lowCD11bhigh phenotype via a TGFB1-dependent mechanism [190].